ArticleInternal medicine (Tokyo, Japan)2025

Maintenance Intravenous Immunoglobulin Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: 18-Month Post-marketing Surveillance in 103 Patients.

Satoshi Kuwabara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.